Hindustan Foods Limited – Investor Presentation Summary
Key Operational Highlights
- Operates 42 factories across 12 states with 175 acres of land bank and 15,000+ strong team
- Manufacturing footprint touches 13 million+ lives daily including 3M+ consumer reach, 1M+ ice cream lovers pleased daily, 50K+ customers reached daily, 4M+ beverage lovers energized daily, millions of families protected and cared for
- Five business segments: Home & Personal Care, Ice Cream, Healthcare, Food & Beverages, Footwear
- Two manufacturing models: Dedicated (₹1,123 crore gross block, 8+ year average contract tenure) and Shared (₹622 crore gross block)
- ROCE investment threshold of 18% with capital allocation following signed contracts
Segment-wise Performance
- Home & Personal Care: Achieved highest-ever liquid category production, completed new product and packaging trials
- Food & Beverages: Expanded portfolio with brownfield Greek Yogurt facility in Goa, strengthening beverages network with juice and water lines
- Ice Cream: Delivered record production volumes during strong summer season, commissioned new state-of-the-art facility in Panipat
- Healthcare: Initiated Class 3 Medical Device certification for EU and UK markets, brownfield expansion for Ayurvedic wellness progressing
- Footwear: Experienced temporary supply chain disruptions due to Middle East crisis impacting material availability and cost
Financial Highlights
Revenue: ₹1,207.0 crore (18% YoY growth, 8% QoQ growth)
EBITDA: ₹106.3 crore (26% YoY growth, 2% QoQ growth)
PAT: ₹42.8 crore (33% YoY growth, 3% QoQ growth) - Highest-ever quarterly profit
EPS: ₹3.53
Margins: Gross Profit margin of 16.4%, EBITDA margin of 8.8%
YoY comparison: Revenue up 18%, EBITDA up 26%, PAT up 33%
Drivers of financial performance: Strong execution momentum, capacity ramp-up, record production volumes
Key Risks: Footwear segment headwinds from raw material inflation and new labor code wage increases
Geographical Revenue Split
Not Specified
Balance Sheet Snapshot
Not Specified
Capex & Cash Flow Health
Capital Expenditure: ₹340 crore in new project wins for FY27 plus ₹150 crore carried forward from FY26
New investments authorized: ~₹190 crore bringing FY27 total to ~₹340 crore
Investment breakdown: Food & Beverages (₹210 crore at Coimbatore, Mysuru, Goa, Aurangabad & Hyderabad), Ice Cream (₹80 crore at Panipat), Home & Personal Care (₹50 crore at Lucknow)
Free Cash Flow: Not Specified
Operating Cash Flow: Not Specified
Investment Rationale: Scaling capacities across high-growth categories, expanding manufacturing footprint
Strategic & R&D Initiatives
- Aurangabad Personal Care Facility: ₹30 crore acquisition completed, production commissioned in Q1 FY27
- Silvassa Liquid Detergent Facility: ₹40 crore, to be commercialized in Q2 FY27
- Lucknow Detergent Bars Facility: ₹50 crore, to be commercialized in Q4 FY27
- Goa Greek Yogurt facility: Brownfield expansion, commercial production targeted for Q3 FY27
- Aurangabad Juice and Water lines: Installation underway, commercial production targeted for Q4 FY27
- Mysore dedicated Water line: Installation underway, commercial production targeted for Q4 FY27
- Coimbatore facility expansion: Capacity enhancement for higher production volumes
- Panipat Ice Cream facility: Phase 2 expansion initiated to support future growth
- Chennai Medical Device certification: For medicated plasters targeting EU and UK markets
Expected impact on growth: ~₹500+ crore worth of projects slated for commissioning in FY27
Industry Trends & Business Environment
- Home & Personal Care: Premiumization, rising disposable incomes, focus on hygiene and wellness, preference for natural and Ayurvedic products
- Food & Beverages: India's packaged food market projected to grow from US$129.18 Bn (2025) to US$238.83 Bn (2034) at ~6.2% CAGR; beverage market from US$80.11 Bn (2025) to US$154.67 Bn (2035) at ~6.8% CAGR
- Ice Cream: Market projected to grow from US$2.07 Bn (2024) to US$4.4 Bn (2030) at ~13% CAGR driven by rising disposable incomes, low per-capita consumption, urbanization
- Healthcare: Market projected to grow from ₹47,000 Cr to ₹98,000 Cr by 2030 at ~13% CAGR driven by preventive healthcare awareness, vitamins & supplements growth, digital healthcare expansion
Impact on Company: Alignment with high-growth categories, expansion into faster-growing segments
Management Commentary & Growth Outlook
Strategic Outlook: "HFL reaffirms its FY27 PAT guidance of Rs.200–220 Cr (34–48% growth over FY26), supported by ramp-up of recently commissioned capacity and a healthy new-project pipeline"
FY Guidance: PAT of ₹200-220 crore for FY27 (34-48% growth over FY26)
Market Share Targets: Not Specified
Risks and Opportunities: Footwear segment headwinds from Middle East crisis-led raw material inflation and new labor code wage increases; customer pass-through discussions underway